ANDREA DEATON: Open Payments
NPI 1376030791 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 44 payments from 17 companies in 2025. Trend: 2023 $302 · 2024 $483 · 2025 $987
Food & beverage: $962Education: $24
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $388 |
| PFIZER INC. | 3 | $83 |
| Corcept Therapeutics | 3 | $79 |
| SpringWorks Therapeutics, Inc. | 3 | $63 |
| Eisai Inc. | 2 | $61 |
| Boston Scientific Corporation | 1 | $49 |
| Abbott Laboratories | 2 | $49 |
| Novo Nordisk Inc | 2 | $42 |
| Seqirus USA Inc | 2 | $36 |
| Lilly USA, LLC | 2 | $29 |
Products named: FARXIGA, BREZTRI, Korlym, GOMEKLI, Leqembi, NURTEC ODT, WaveWriter Alpha Prime 16, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
